Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Vanda Pharmaceuticals Inc. (VNDA) had Current Ratio of 2.39 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$57.22M |
|
$-141.19M |
|
$3.83M |
|
$53.38M |
|
$97.57M |
|
$-40.35M |
|
$2.35M |
|
$-38.00M |
|
$-38.00M |
|
$-141.19M |
|
$-141.19M |
|
$-141.19M |
|
$-141.19M |
|
$-40.35M |
|
$-34.75M |
|
58.93M |
|
58.93M |
|
$-2.40 |
|
$-2.40 |
|
| Balance Sheet Financials | |
$347.26M |
|
$2.25M |
|
$141.69M |
|
$488.95M |
|
$145.16M |
|
$4.08M |
|
$16.60M |
|
$161.76M |
|
$327.19M |
|
$210.10M |
|
$327.19M |
|
59.10M |
|
| Cash Flow Statement Financials | |
$-109.44M |
|
$94.86M |
|
$-2.91M |
|
$102.78M |
|
$85.32M |
|
$-17.46M |
|
$9.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
2.39 |
-- |
|
-- |
|
0.01 |
|
0.01 |
|
93.30% |
|
-70.53% |
|
-70.53% |
|
-- |
|
-66.42% |
|
-246.76% |
|
$-110.44M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
2.07 |
|
1.05 |
|
85.85 |
|
-43.15% |
|
-67.20% |
|
-28.88% |
|
-42.62% |
|
$5.54 |
|
$-1.87 |
|
$-1.86 |
|